Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)
Year: 1999
Type: article
Source: Controlled Clinical Trials
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1990675333
